Quick ReadPlain-language overview · read this first
CRH is a North American and international building-materials leader, using its aggregates-cement-roads-infrastructure-outdoor living connected portfolio to serve government, general-contractor, and utility customers; 95% of revenue is aggregates-related, and its arena is a local oligopoly within a mature cycle. Rating: Cautious Buy—a good company sitting close to its conservative intrinsic value, but with a thin margin of safety that rests on continued execution rather than a low price.
2025 revenue was US$37.4 billion, net profit US$3.8 billion, and operating cash flow US$5.6 billion, with cash flow/net profit at 140-160% for three straight years; after deducting US$970 million of maintenance capex, owner earnings were about US$4.7 billion. The current price of US$100.37 corresponds to 14.4x owner earnings and 10.6x EV/EBITDA, clearly cheaper than the two pure-play U.S. aggregates leaders Vulcan and Martin Marietta. The problem is that M&A intensity was too high in 2024-2025: net debt rose all the way from US$10.5 billion to US$14.2 billion, adjusted ROIC fell from 13.4% to 12.1%, acquisition-related costs were US$78 million, and M&A still contributed -US$10 million to net profit that year, so the easiest phase of value release may already be over.
The conservative intrinsic value band is US$80-105, base US$110-145, and optimistic US$150-200, with the current price close to the conservative upper bound. Ideal buy: US$85-100, with better value around US$90. The reverse trigger conditions are clear: net debt/EBITDA breaking above 2.5x without ROIC improving, cash-conversion rate persistently below 80%, weakening North American materials pricing power, and a large goodwill impairment—if any one occurs, it slides from "a good company at a fair price" to "a good company at a bad price," and a 30%-45% medium-term drawdown would not be exaggerated.
LeadA leading North American and international building-materials company whose connected portfolio spans aggregates, cement, roads, water, and landscaping. At the current US$100.37 the stock sits close to its conservative intrinsic value, with an ideal buy range of 85-100; the margin of safety is thin and rests on continued execution rather than on a low price. Rating: Cautious Buy.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
Preliminary Rating: Cautious Buy
Current Price and Margin of Safety: As of May 22, 2026 (U.S. Eastern Time), CRH traded at US$100.37 per share, with a market cap of about US$67.1 billion and a trailing P/E of roughly 18.6x. From a long-term owner's perspective, the current price offers some margin of safety, but not a thick one: it is clearly below the relative valuation of pure-play U.S. aggregates peers, yet it is not quite "cheap enough to win even if you're wrong."
Suitable Investor Type: It is better suited to long-term value investors and infrastructure/materials investors who can tolerate moderate cyclical swings; it is less suitable for ordinary investors who want to hold it as a "no-brainer, high-certainty consumer stock." CRH is a good business, but it does not operate in a cycle-free industry; rather, it sits in an industry that is highly cyclical, capital-intensive, and dependent on execution and capital allocation.
Core Judgment: CRH's business is fundamentally understandable: it relies on a "connected portfolio" spanning the construction value chain—aggregates, cement and binder materials, road solutions, critical infrastructure building materials, and outdoor living products—to serve governments, utilities, general contractors, and commercial and residential customers, making money through local networks, vertical integration, and scale advantages. The company holds leading positions in both North American and international markets. In 2025 it posted revenue of US$37.447 billion, net profit of US$3.790 billion, and operating cash flow of US$5.625 billion, and it disclosed maintenance capital expenditure of US$971 million, which makes its "true distributable cash flow" markedly better than its accounting net profit. At the same time, CRH's capital allocation history has been better than the industry average overall, but M&A was heavy in 2024-2025, net debt rose, and ROIC declined, which means the investment conclusion depends heavily on management's ability to integrate going forward.
Biggest Uncertainties: First, M&A intensity has been very high over the past two years; in 2025 net debt rose to US$14.151 billion, and adjusted ROIC fell from 13.4% to 12.1%—if integration goes poorly, value creation will slow. Second, residential demand remains soft, and CRH needs infrastructure, water, and reindustrialization to offset the volatility on the housing side. Third, cement/binder materials are a high-emission segment, and future carbon costs, environmental capex, and product substitution will affect long-term marginal returns.
Understanding the Business and the Industry Landscape
Is this a business I can understand? My conclusion: yes, but you have to accept its "local oligopoly + heavy-asset cyclical" nature.
【Fact】 CRH divides its business into three major segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. In 2025 the three segments generated revenue of US$17.029 billion, US$7.122 billion, and US$13.296 billion, respectively. By product, in 2025 CRH's main revenue came from Road Solutions US$17.089 billion, Essential Materials US$10.374 billion, Building & Infrastructure Solutions US$4.868 billion, and Outdoor Living Solutions US$5.116 billion. The company describes its "connected portfolio" as covering the construction value chain, drawing on deep local relationships, scale, and integration capabilities to supply materials and services for transportation, water, reindustrialization, and commercial and residential construction.
From the customer angle, CRH serves federal and local governments, general contractors, commercial customers, and the residential market, as well as builders of energy, communications, water, and other infrastructure. Its ways of charging are not complicated: first, selling materials; second, selling road/construction services; and third, providing systematized products and solutions in certain businesses. It is neither a subscription business nor an asset-light platform, but much of its revenue comes from recurring, persistent local-market demand for infrastructure maintenance and construction—so while it is affected by project timing in the short term, long-term demand is not fragile.
The revenue stability of this business is above average—not the smooth curve of consumer goods, but also not the purely one-off nature of developer projects. The reasons: on one hand, the five-year appropriations for U.S. federal highways and related projects are still flowing—the IIJA provides roughly US$350 billion for federal highway projects in fiscal years 2022-2026; on the other hand, the EPA estimates that drinking-water systems will still need US$625 billion of investment over the next twenty years. In other words, much of the end demand CRH faces is not "optional" but hard infrastructure that an economy must continually maintain and upgrade.
But to be honest, this is not an easy business "with no technology, no cycle, and no capital consumption." In its cost structure, raw materials, energy, labor, transportation, depreciation, and equipment maintenance all matter; meanwhile, the residential side is still affected by interest rates and the mortgage environment. In April 2026, U.S. single-family housing starts ran at an annualized 930,000 units, down 9.0% month-over-month, showing that the housing side has not entered a strong upcycle. The good news for CRH is that it increasingly resembles an "infrastructure and utility-network modernization company"; the bad news is that it still cannot escape the construction cycle.
If the stock market were closed for five years, would I be willing to hold it? Yes, but only if the purchase price is not too aggressive. This is because CRH does not create value by telling an emotional story, but through real assets, real cash flow, real M&A integration, and expanding local market share; yet it is also not the kind of "perpetual compounding machine" that can ignore the macro cycle. This is a business worth understanding and holding for the long term, but not one you can buy blindly without regard to price. Business Understandability Score: 4.5/5.
Industry and Competitive Landscape
By industry nature, building materials—especially aggregates, cement, asphalt, road construction, and related infrastructure materials—typically sit in a cyclical branch of a mature industry. Long-term demand is stable, but quarterly and annual profits are affected by weather, interest rates, residential construction, public budgets, energy prices, and the pace of M&A integration. It is not a high-growth industry, but it benefits from U.S. roads, water, power, data centers, and manufacturing reindustrialization, and over the next decade it is not a "sunset industry" in the traditional sense.
CRH itself anchors its future growth to four major directions—infrastructure, transportation, water, and reindustrialization—and at its 2025 Investor Day positioned itself as the "number-one beneficiary of North American infrastructure." Such claims naturally carry management's promotional coloring, but they are consistent with the external environment of U.S. road appropriations, aging water-system renewal, manufacturing construction, and data-center investment.
Competitively, the strongest pure-play U.S. comparables are Vulcan Materials and Martin Marietta. Vulcan is the U.S. aggregates leader, while Martin Marietta is a powerhouse in aggregates and heavy building materials. CRH differs in that it is not a single-product U.S. aggregates company but a more complex combination that is North America-focused, internationally supplemented, and spanning aggregates—binder materials—roads—water and critical infrastructure—outdoor living. Put simply, VMC/MLM are more "pure," while CRH is more "complete." Higher purity means a higher valuation at certain times; greater breadth means a larger capital-allocation runway, and also higher demands on management.
As for industry attractiveness, I would classify it as "an excellent company in an average industry," rather than "a good company in an inherently good industry." The industry's biggest advantages are strong localization, short transport radius, scarce permits, and high replacement costs; its biggest drawbacks are capital intensity, cyclical volatility, and policy/environmental constraints. Industry Attractiveness Score: 3.5/5.
Moat and Management
Moat assessment: it exists, but it is mainly a composite moat of "local resources + network footprint + operational execution + capital allocation," rather than a consumer-brand-style moat.
| Moat Dimension | Conclusion | Basis and Explanation |
|---|---|---|
| Brand advantage | Moderate | In B2B/government procurement and local engineering systems, CRH wins on reputation, delivery, product systems, and local relationships, but this is not a Coca-Cola-style brand. |
| Cost advantage | Fairly strong | Aggregates and road materials depend heavily on transport radius; a local network close to demand and reserves is itself a cost advantage. |
| Scale advantage | Strong | CRH operates in 28 countries at about 4,000 locations, and is a leader in both North America and internationally. |
| Network effects | Weak | Not a platform-type network effect. |
| Switching costs | Low to medium | Customers are not locked in by software, but engineering specifications, historical cooperation, supply stability, and local certification create some stickiness. |
| Channel advantage | Strong | Quarries, terminals, road construction, and critical-infrastructure products form a "one-stop" supply chain. |
| License/regulatory barriers | Medium to strong | Quarries, road construction, environmental permits, and local approvals naturally raise the difficulty of replication. |
| Data advantage | Weak to medium | There is some operational and dispatch data advantage, but it is not a core source of the moat. |
| Corporate culture/operating capability | Strong | Long-term margin expansion, cash conversion, and cross-cycle operating discipline are important advantages. |
| Capital allocation capability | Medium to strong | Historically better than the industry, but it still needs continued validation after the past two years' large acquisitions. |
The core evidence behind the judgments above is that CRH itself emphasizes its unmatched scale, connected portfolio, and deep local relationships, and disclosed at its Investor Day that about 95% of revenue is aggregates-related. This means the company's competitiveness does not come from a single star product, but from the local resource control, transport network, and upstream-downstream connectivity built around aggregates—a low value-to-weight category. This kind of advantage is most vulnerable to local permits being breached and to a loss of pricing discipline, but once established, it is generally not easy to replicate quickly.
The moat is stable and slightly widening, especially in North American infrastructure, water, and reindustrialization. There are three reasons. First, industries that are transport-heavy, permit-heavy, and local-relationship-heavy tend to become more oligopolistic through M&A integration. Second, CRH's connected portfolio lets it elevate single-product selling points into "project solutions." Third, management explicitly plans to have about US$40 billion of financial capacity over 2026-2030, of which about 70% will go to growth investment and about 30% to shareholder returns, meaning it intends to continue value-accretive expansion in fragmented markets.
For a competitor to replicate CRH's local network and portfolio capabilities, it would typically need many years, several billion dollars of capital, local permits, and sustained M&A integration. This is not the one-off copying of the software industry, but a moat built up jointly from "assets—relationships—operations—regulation—capital." At the same time, one must also acknowledge that this moat is not absolutely defensive. When residential demand weakens, energy prices rise, or M&A becomes excessive, margins can still be affected. In other words, CRH's advantage makes it more resilient than its peers, not "immune to the cycle."
Management and Capital Allocation
On governance, CRH's executive incentive framework is more American-style shareholder-oriented than that of many European industrial companies. Starting in 2025, the company imposes equity-holding requirements on NEOs and non-executive directors: the CEO must hold stock equal to 6x annual salary, and other NEOs 3x annual salary, with a 75% net-share retention requirement on restricted/performance shares until the threshold is met. The company also has anti-hedging, anti-pledging, and clawback arrangements, and its 2025 "Say on Pay" support rate was 94.57%. This indicates that the governance framework generally values long-term alignment.
But if you are a Buffett-style investor, you would still ask one more question: do they themselves hold a lot? The answer here is: yes, but not at founder level. As disclosed in early 2026, CEO Jim Mintern directly/indirectly beneficially holds about 57,612 shares, and CFO Nancy Buese about 16,833 shares; other executives also hold shares, but this is not "nearly their entire net worth tied to the company" super-alignment. Therefore, my judgment on management is: institutional alignment is fairly strong, and personal-wealth-level binding is moderate.
The capital allocation history overall deserves a high score, but not a perfect one. Evidence supporting a high score includes the company's long-term margin expansion, strong operating cash flow, and sustained dividends and buybacks; in 2025 it repurchased 11.70 million shares at an average price of US$100.91 per share, and in 2024 it repurchased 15.87 million shares at an average price of US$82.01 per share, with the total share count clearly declining over the past several years. What holds my score back is that 2025 acquisition-related costs reached US$78 million, and while acquisitions contributed US$755 million of revenue in 2025, their contribution to net profit was still -US$10 million; meanwhile net debt rose from US$10.532 billion in 2024 to US$14.151 billion in 2025, and adjusted ROIC fell from 13.4% to 12.1%. This suggests the direction of the M&A is not necessarily wrong, but "whether the money is starting to become harder to earn" is worth watching closely.
Overall, I believe management has good honesty and long-term orientation, and its capital-allocation capability was historically excellent but is currently at a stage that requires re-validation. Moat Strength Score: 4/5. Management and Capital Allocation Score: 4/5.
Financial Quality and Owner Earnings
First, an important caveat on accounting basis: the public annual reports for 2020-2022 were under IFRS, while the 2023-2025 10-K statements are presented under U.S. GAAP. Add to this the significant changes in the business mix over these years, and long-table comparisons that span 2022/2023 are useful for reference but are not mechanically comparable. The table below has been standardized as much as possible, and where necessary it distinguishes between "simple free cash flow" and "management-defined adjusted free cash flow."
Key Financial Metrics Table
| Year | Revenue | Revenue YoY | Operating profit | Operating margin | Net profit | Net margin | Operating cash flow | Total capex | Simple free cash flow | Year-end net debt | Diluted shares | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | $25.888B | — | $2.026B | 7.8% | $0.966B | 3.7% | $3.938B | $0.996B | $2.942B | $5.941B | 785.1M | IFRS; still positive cash flow in the pandemic year |
| 2021 | $29.206B | 12.8% | $3.331B | 11.4% | $2.386B | 8.2% | $4.210B | $1.554B | $2.656B | $6.253B | 780.2M | Profit sharply recovered |
| 2022 | $32.723B | 12.0% | $3.894B | 11.9% | $2.657B | 8.1% | $3.954B | $1.523B | $2.431B | $5.105B | 758.3M | Debt improved |
| 2023 | $34.949B | 6.8% | $4.186B | 12.0% | $3.072B | 8.8% | $5.017B | $1.817B | $3.200B | $5.406B | 729.2M | U.S. GAAP |
| 2024 | $35.572B | 1.8% | $4.925B | 13.8% | $3.521B | 9.9% | $4.989B | $2.578B | $2.411B | $10.532B | 689.5M | M&A pushed up leverage |
| 2025 | $37.447B | 5.3% | $5.440B | 14.5% | $3.790B | 10.1% | $5.625B | $2.713B | $2.912B | $14.151B | 677.0M | Record profit and cash flow |
Data source note: Revenue, operating profit, profit attributable to owners, assets, and share count for 2020-2022 come from the "Key Financial Data" of CRH's 2022 annual report; 2020-2022 operating cash flow and capex come from the 2022 cash flow statement; 2023-2025 revenue, operating profit, net profit, share count, balance sheet, and cash flow come from the 2025 Form 10-K.
By trend, CRH's revenue CAGR over 2020-2025 was about 7.7%, operating cash flow CAGR about 7.4%, while diluted shares fell about 14%—that is, per-share compounding was stronger than aggregate compounding. In 2025 the operating margin rose to 14.5%, above the 7.8% of 2020; this shows the company's profit improvement was not merely a cyclical rebound but also came from portfolio optimization, pricing discipline, cost control, and a higher share of higher-quality businesses.
Cash flow quality is one of CRH's most commendable features. The company disclosed that in 2023-2025 its operating cash flow/net profit was 163%, 142%, and 148%, respectively, and management-defined adjusted free cash flow was US$4.255B, US$4.225B, and US$4.969B; this means profits do not mostly get stuck in receivables or inventory, but genuinely convert to cash. In 2025, receivables and inventory rose slightly, and accounts payable made a negative contribution to cash flow, but overall it still maintained strong operating cash flow—I did not see the typical "great profit, poor cash" accounting red flag.
The balance sheet remains solid, but it is more "aggressive" than two years ago. At the end of 2025, short- and long-term debt totaled US$17.653 billion, cash was US$4.096 billion, and net debt was US$14.151 billion; by the company's measure, 2025 net debt/EBITDA was about 1.8x, versus about 1.5x and 0.9x in 2024 and 2023. Meanwhile, 2025 interest expense was US$810 million against operating profit of US$5.440 billion, for an EBIT/interest coverage ratio of about 6.7x. For a heavy-asset, acquisition-driven building-materials leader, this leverage is not dangerous, but it does mean "the next round of M&A must keep making money," or financial flexibility will keep narrowing.
On return on capital, using the company's official measure, CRH's adjusted ROIC was 13.3%, 13.4%, and 12.1% in 2023, 2024, and 2025, respectively. This is still a decent level, but the 2025 decline deserves attention. Using a rougher "NOPAT / (shareholders' equity + net debt)" estimate, 2025 also came in at roughly 11%, showing that the business quality is genuinely real, but returns did not keep rising after the acquisition wave.
Owner Earnings Analysis
Buffett-style "owner earnings" focuses more on: after maintaining its competitive position, how much real money can this company actually leave for owners? CRH in fact offers a good starting point, because it separately discloses maintenance capital expenditure. In 2025 the company's operating cash flow was US$5.625 billion and maintenance capex was US$971 million; management's adjusted free cash flow was US$4.969 billion, which added back US$315 million of income from long-term asset disposals. Taking a more conservative approach and not counting disposal income in owner earnings, I prefer to define 2025's conservative Owner Earnings as: Owner Earnings ≈ operating cash flow US$5.625 billion - maintenance capex US$971 million = US$4.654 billion.
This measure has several advantages. First, it sidesteps the accounting complexity brought by M&A; second, it directly reflects "how much money is left after maintaining the existing asset base"; third, it fits the economic reality of a building-materials leader better than a simple "operating cash flow minus total capex," because total capex includes a large amount of expansionary projects. On this basis, CRH's 2025 owner earnings are markedly higher than net profit, showing this is a company whose real cash profit is stronger than its accounting net profit, not the other way around.
Based on the current market cap of about US$67.1 billion, CRH's owner-earnings multiple is about 14.4x, and its owner-earnings yield is about 6.9%. This is not "cigar-butt" cheap, but for a company with regional-oligopoly characteristics, a long-term compounding record, and platform-M&A attributes, it is a still-acceptable price that nonetheless demands continued excellent execution. By comparison, on the simple free-cash-flow basis, P/FCF is about 23x, showing that your judgment on CRH depends largely on whether you believe its growth capex and M&A create value rather than consume cash.
Valuation and Margin of Safety
Method 1: Owner Earnings Discounting
The valuation below is my model, not company guidance. 【Fact】 The valuation starts from 2025's conservative Owner Earnings of US$4.654 billion; the directional 2030 targets the company gave at its 2025 Investor Day are: average revenue growth of 7%-9% over 2026-2030, a 2030 adjusted EBITDA margin of 22%-24%, and an adjusted free cash flow conversion rate above 100%. 【Assumption】 To be conservative, my base/optimistic scenarios are all below or close to this framework, and do not factor in any additional future per-share buyback gains.
| Dimension | Conservative | Base | Optimistic |
|---|---|---|---|
| Starting Owner Earnings | $4.50B | $4.65B | $4.80B |
| First-decade growth | 3.0% | 5.5% | 7.5% |
| Discount rate | 9.0% | 8.5% | 8.0% |
| Terminal growth | 2.0% | 2.5% | 3.0% |
| Estimated intrinsic value | $70.6B | $100.0B | $141.2B |
| Per-share value | ~US$104 | ~US$148 | ~US$209 |
【Opinion】 I believe what really matters is not "how high the optimistic value is," but "how far the conservative value is from the current price." In this model, the current share price of US$100.37 is roughly close to the conservative valuation and below the base valuation. So it is neither deeply undervalued nor a bubble price. If over the next decade CRH only delivers low-single-digit growth, returns will most likely still be positive; if it can sustain mid-single-digit to high-single-digit owner-earnings growth, then long-term returns will clearly beat bonds. Conservative intrinsic value range: US$80-105 Fair intrinsic value range: US$110-145 Optimistic intrinsic value range: US$150-200 and above
Method 2: Relative Valuation
| Company | Current market cap | P/E | P/B | EV/EBITDA | Simple P/FCF | Notes |
|---|---|---|---|---|---|---|
| CRH | $67.1B | 18.6x | 2.8x | 10.6x | 23.0x | Diversified platform, North America + international |
| Vulcan Materials | $34.2B | 31.0x | 4.0x | 16.5x | 30.1x | A purer U.S. aggregates leader |
| Martin Marietta | $32.4B | 12.8x* | 3.2x | 16.4x | 33.1x | *TTM P/E is heavily distorted by asset transactions |
Data and basis note: Current share prices, market caps, and P/E come from market quotes; the EBITDA, debt, cash, and cash flow for VMC and MLM come from their latest public annual reports/full-year results; CRH's EBITDA, net debt, and cash flow come from its 2025 Form 10-K. Martin Marietta's P/E is affected by non-recurring factors and should not be directly compared with CRH's.
The conclusion from this table is clear: CRH is not the cheapest "accounting P/E" stock in the industry, but by EV/EBITDA, P/B, and free cash flow it is significantly cheaper than the pure-play U.S. aggregates leaders. This is reasonable to some degree, because CRH has a more complex portfolio, more international business, and heavier M&A; but even accounting for these discount factors, 10.6x EV/EBITDA is still in a reasonable-to-low range for a leader with high cash conversion, a stable moat, and large North American infrastructure exposure. 【Inference】 If the market is willing to give it 11.5-13.0x EV/EBITDA in the future, the corresponding equity value falls roughly at US$109-127 per share. This provides a "not exaggerated but reasonably clear" relative-valuation support for the current price.
Method 3: Asset or Liquidation Value
This method is not suitable as CRH's primary valuation method, but it can remind you not to buy CRH as a "discount-to-net-asset stock." At the end of 2025, CRH's total assets were US$58.329 billion, total shareholders' equity was US$25.048 billion, and equity attributable to CRH shareholders was US$24.004 billion; the books carried US$13.099 billion of goodwill and US$2.048 billion of intangible assets. This means that if you look at "tangible net assets," CRH is not cheap.
But on the other hand, book value also understates many things that are truly hard to replicate: local quarry permits, logistics networks, terminal and road-construction systems, local brand relationships, upstream-downstream synergies, and management systems. These are not fully reflected in accounting net assets. So my conclusion on the asset method is: CRH's value comes mainly from ongoing operations and capital allocation, not from a liquidation discount. If you buy it, you are buying the next decade's cash flows and scarce footprint, not some "book-asset safety cushion." This also means that once operating quality deteriorates, the asset method cannot give you a very thick floor.
Price Range Assessment
Ideal buy range: US$85-100 Basis: at or below the upper bound of conservative intrinsic value, with a discount of more than about 20% to the base valuation.
Acceptable holding range: US$100-125 Basis: base value still has room, but the margin of safety gradually thins.
Clearly overvalued range: above US$145 Basis: at or beyond the lower bound of fair valuation under the more optimistic scenario.
Margin of Safety Conclusion
For the margin of safety at the current price, I offer a more sober statement: "There is one, but it rests mainly on continued execution, not on a low price itself." The two most fragile valuation assumptions are: first, that M&A keeps creating value; second, that infrastructure/water/reindustrialization can indeed offset the weakness on the residential side. If future growth falls short of expectations and margins soften slightly, CRH still would not necessarily cause permanent capital loss; but if margin decline + return-on-capital decline + valuation-multiple contraction occur simultaneously, it would turn from "a good company at a fair price" into "a good company at a bad price." So I believe now is not a price at which you must stay in cash and wait, but if the market offers around US$90 or lower, the risk-reward would be clearly better.
Risks, Comparisons, and Final Judgment
The Most Important Risks and Counterarguments
The first type of risk is cyclical risk. CRH's residential and general commercial construction businesses are still affected by interest rates and the credit environment. Recent U.S. single-family housing starts and permits have not been strong, which will drag on some end demand. The second type of risk is M&A and integration risk. In 2025, acquisition-related costs were US$78 million, and while acquisitions contributed revenue that year, they did not contribute positive net profit, even as ROIC declined and net debt rose. If large acquisitions in the coming years fail to meet return targets, shareholder value will be diluted. The third type of risk is regulatory and carbon risk. The binder-materials and cement businesses naturally face emissions, energy, and environmental constraints, which may require higher capex in the future. The fourth type of risk is overvaluation risk: although CRH is not expensive relative to U.S. peers, for conservative investors the current price is still not a low one with "a huge margin for error."
The strongest counterargument goes roughly as follows: CRH is not an "undervalued simple leader," but a complex heavy-asset platform that has been well regarded for a while on the tailwinds of an industry upcycle and M&A. Bears would point out that a large part of the company's margin improvement may come from the cycle, the pricing environment, and portfolio-optimization dividends; starting in 2025, leverage rose, acquisitions increased, and ROIC declined, suggesting the easiest phase of value release may already be over. If U.S. residential stays weak, public spending decelerates at the margin, and integration results fall short, then CRH's "discount" today may only be a fair discount rather than genuine undervaluation.
Which Facts Would Overturn the Investment Thesis
If the following facts emerge over the next two to three years, I would concede that the investment logic has clearly worsened: First, net debt/EBITDA persistently rising above 2.5x, without margins and ROIC improving in tandem; Second, Owner Earnings/Adjusted FCF conversion rate persistently falling below 80%, indicating that growth is increasingly "consuming cash"; Third, the pricing and share advantages of the North American materials business weakening, with the international business unable to compensate; Fourth, a clear large goodwill impairment, especially one related to recent acquisitions; Fifth, management beginning to emphasize scale rather than per-share intrinsic value growth.
The Worst Permanent Capital Loss Scenario
The worst case is not short-term share-price volatility, but the combination of "buying high + M&A failure + cyclical downturn + rising regulatory capex." If this happens, CRH as a heavy-asset company would not easily collapse, but your ten-year return could be compressed close to that of bonds, or even clearly underperform the index—this is what long-term investors should truly worry about.
Comparison with Other Opportunities
Compared with its strongest industry rivals, Vulcan's business is purer and its moat more "standardized," but its valuation is also significantly higher; Martin Marietta's aggregates quality is equally excellent, but its recent asset transactions distort its reported earnings basis more heavily. CRH's advantage is that you buy a broader asset portfolio and a stronger capital-allocation platform at a lower EV/EBITDA and P/B. CRH's weakness is that it is not as "pure" as VMC, and therefore relies more on management.
Compared with a broad-based index, my judgment is: CRH is not "clearly better than buying the index" to the degree that it must be a heavy position, but at the current valuation it qualifies as an industry-leader position within a portfolio. For an ultra-lean portfolio of just five assets, I would say it barely qualifies for inclusion, but is not an unconditional top five. The reason: its long-term return outlook is decent, but industry cyclicality and M&A complexity make it less reassuring than a top-tier consumer monopoly or software platform. If your capital can only go into the "simplest, most stable, least macro-dependent" names, CRH may not make the top five; if you are willing to allocate to a hard-asset platform tied to real assets, U.S. infrastructure, water, and reindustrialization, then CRH is quite attractive.
Compared with the risk-free rate, the U.S. 10-year Treasury yield on May 21, 2026, was about 4.57%. CRH's yield estimated on conservative Owner Earnings is about 6.9%, and adding dividends and long-term reinvestment potential, it can in theory offer an expected return above Treasuries; but relative to bonds, this excess return is not exaggerated, so the buy price remains crucial.
Investment Checklist
The table below is the checklist-style answer you requested. It is an integrated judgment based on the facts above, not a new statement of fact.
| Item | Conclusion |
|---|---|
| Can I understand this business? | Pass |
| Does it have long-term stable demand? | Pass |
| Does it have a durable moat? | Pass |
| Does it have pricing power? | Pass, but limited |
| Can it generate stable free cash flow? | Pass |
| Is its return on capital excellent? | Pass, but recently declined |
| Is management trustworthy? | Pass |
| Is capital allocation rational? | Pass, but M&A needs continued validation |
| Is the balance sheet solid? | Pass |
| Is the valuation below intrinsic value? | Pass, but not by much |
| Is the margin of safety sufficient? | Uncertain, moderate |
| Does long-term holding put me at ease? | Pass, but less so than a non-cyclical monopoly |
| Which key facts would make me sell? | ROIC deterioration, rising leverage, worsening cash conversion, M&A impairment |
| Am I buying only because of a rising price or market sentiment? | No; the decision should be based on cash flow and valuation |
Final Investment Conclusion
【Final Rating】 Cautious Buy
【One-Sentence Investment Thesis】 CRH is a building-materials and infrastructure platform that combines local resource barriers, a connected product portfolio, and a good capital-allocation record; the current valuation is not cheap to the extreme, but it already carries a discount relative to the pure-play U.S. aggregates leaders—enough to support prudent long-term buying.
【Core Bull Case】
Dual leadership in North America and internationally, with the business deeply tied to long-term rigid demand such as transportation, water, and reindustrialization.
Revenue, profit, operating cash flow, and adjusted EBITDA all hit records in 2025, with high cash-conversion quality.
The moat comes from local resources, transport radius, permits, network footprint, and upstream-downstream connectivity, and is not easily replicated quickly.
Relative to VMC and MLM, CRH's EV/EBITDA, P/B, and cash-flow valuations are clearly lower.
Management's governance framework is fairly mature, with equity-holding requirements, buybacks, dividends, and clawback mechanisms.
【Core Bear Case】
Building materials is still a cyclical industry, not a high-certainty consumer product; residential-side weakness will drag on some demand.
M&A intensity was high in 2024-2025, net debt rose sharply, and ROIC declined instead.
The current price, while not expensive, is not deeply undervalued either; the margin of safety relies more on continued execution than on a low price.
The cement/binder-materials business faces long-term carbon-cost and environmental-capex pressure.
Management has some personal-shareholding alignment, but not founder-style strong binding.
【Key Assumptions】
North American infrastructure, water, and reindustrialization continue to provide medium- to long-term demand support.
M&A integration can stabilize ROIC in the double digits without persistently eroding the balance sheet.
Owner Earnings can be maintained in the US$4.5-5.0 billion range and grow steadily.
Industry pricing discipline and local supply constraints remain in place.
【Fair Buy Price】 US$85-100 per share. Basis: roughly corresponds to the conservative intrinsic value range and a clear discount to the base value; in this price band, even if future growth is only low single digits, the long-term return is more acceptable.
【Target Holding Period】 At least 5-10 years, preferably more than 10 years. This is not a stock suited to quarterly sentiment trading; its real value comes from cross-cycle operations, M&A integration, and per-share cash-flow compounding.
【Expected Annualized Return】
Conservative scenario: 5%-6%
Base scenario: 8%-10%
Optimistic scenario: 11%-13%
These ranges are not price forecasts, but an integrated estimate based on owner-earnings growth, dividends, moderate buybacks, and a valuation reversion toward a reasonable range.
【Maximum Loss Risk】 If, after buying, you encounter "cyclical downturn + M&A failure + valuation contraction," a 30%-45% market-cap drawdown in the medium term would not be surprising; if capital allocation clearly misfires and triggers a long-term ROIC decline, underperforming the index over a ten-year horizon is also possible. For long-term investors, the real maximum loss is not book-value volatility, but buying at a position without a sufficient margin of safety, followed by a structural decline in the company's rate of return.
【Tracking Metrics】
Revenue and margins of Americas Materials Solutions
Whether the adjusted EBITDA margin continues to approach or move toward the 22%-24% direction
Owner Earnings / Adjusted FCF conversion rate
Net debt / EBITDA
Adjusted ROIC
M&A contribution and integration progress
Changes in residential, non-residential, road, and water end demand
The ratio of maintenance to growth capex within capital expenditure
Buyback amount, buyback price, and changes in per-share count
Major impairments or environmental/carbon-related capex changes
【Signals Triggering Reassessment】
ROIC clearly declining for two consecutive years
Net debt/EBITDA rising above 2.5x
Operating cash flow clearly lagging net profit
A large M&A impairment or synergies falling short of expectations
North American infrastructure growth failing to offset residential weakness
Management starting to emphasize revenue scale rather than per-share value growth
【Open Questions and Limitations】
I did not obtain a sufficiently consistent, fully same-basis 2020-2025 full-cycle ROA/ROIC history, so certain ratios spanning IFRS and U.S. GAAP can only be compared approximately.
The asset/liquidation method is not well suited to a company like CRH, whose quarry permits and local-network value are strong, so that section is better used as a "floor-thinking" exercise than as a primary pricing tool.
M&A returns after 2026 still need continued validation from subsequent financial reports; this is currently the new variable most in need of tracking.
【Final Recommendation】 The sober conclusion is not that "CRH will surely surge," but that "CRH is most likely a good company worth holding for the long term, at a current price that allows you to start holding it seriously, but one that is not yet cheap enough to lose your discipline." If you are a balanced, slightly conservative investor with a horizon of ten years or more, I would put it on the list of "positions you can build in tranches while keeping ammunition for lower-price add-ons"; if you only act at a very thick margin of safety, then the more ideal patient entry point is roughly around US$90 or lower.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free